BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8869949)

  • 1. Immunologic responses to human papillomavirus infection.
    Gissmann L
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):625-39. PubMed ID: 8869949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the immune system in anogenital human papillomavirus.
    Frazer IH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccine development.
    Fife KH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S8-10. PubMed ID: 9842094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].
    Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V
    Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.
    Stern PL
    J Clin Virol; 2005 Mar; 32 Suppl 1():S72-81. PubMed ID: 15753015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host response to lesions induced by human papillomavirus.
    Stanley M; Coleman N; Chambers M
    Ciba Found Symp; 1994; 187():21-32; discussion 32-44. PubMed ID: 7796671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunology of genital human papilloma virus infection.
    Stanley M
    Eur J Dermatol; 1998; 8(7 Suppl):8-12; discussion 20-2. PubMed ID: 10387957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and serological manifestations of genital human papillomavirus infection.
    Wikström A
    Acta Derm Venereol Suppl (Stockh); 1995; 193():1-85. PubMed ID: 8721519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to human papillomavirus infection.
    Carter JJ; Galloway DA
    Clin Dermatol; 1997; 15(2):249-59. PubMed ID: 9167909
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D; Seilles E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
    Sobhani I; Walker F; Aparicio T; Abramowitz L; Henin D; Cremieux AC; Soule JC
    Clin Cancer Res; 2002 Sep; 8(9):2862-9. PubMed ID: 12231528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early anti-HPV 16 protein antibodies in patients with anogenital tumors].
    Marcheş F; Stoian M; Repanovici R
    Rev Roum Virol; 1992; 43(3-4):149-54. PubMed ID: 1339204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vulvo-vaginal HPV infection: immunological aspects].
    Zarcone R; Bellini P; Cardone G; Castagnolo A; Colacurci N
    Minerva Ginecol; 1996 Mar; 48(3):61-3. PubMed ID: 8684688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti-HPV monoclonal antibody.
    Iwasaki T; Sata T; Sugase M; Sato Y; Kurata T; Suzuki K; Ohmoto H; Iwamoto S; Matsukura T
    J Pathol; 1992 Nov; 168(3):293-300. PubMed ID: 1335045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
    Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
    J Infect Dis; 2000 Jun; 181(6):1911-9. PubMed ID: 10837170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus.
    Unger ER; Vernon SD; Lee DR; Miller DL; Sharma S; Clancy KA; Hart CE; Reeves WC
    Arch Pathol Lab Med; 1997 Aug; 121(8):820-4. PubMed ID: 9278609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of papillomavirus capsid antigens and human papillomavirus 16-related DNA in Bowenoid papulosis and Bowen disease].
    Gross G; Ikenberg H; Hagedorn M; Gissmann L
    Z Hautkr; 1984 Aug; 59(16):1084-6. PubMed ID: 6091356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.